China Donates 200,000 Covid Vaccines to Zimbabwe, President Says
(Bloomberg) -- China donated 200,000 doses of coronavirus vaccines to Zimbabwe, which will help kick-start the government's roll-out of inoculations, President Emmerson Mnangagwa said.
“Covid-19 vaccines which have been scientifically ascertained to be safe will soon be introduced,” Mnangagwa said in a televised address Thursday. “These will be state-funded and free.”
His comments came a day after Finance Minister Mthuli Ncube told state media that citizens would be expected to pay for vaccines, with the government only covering the cost of doses for the most vulnerable groups. Ncube, later backtracked on the comments, saying they were “taken out of context.”
Health-care workers and those most at risk will be the first to receive shots, which include China's SinoPharm vaccine, Mnangagwa said.
“We applaud China for contributing to our national vaccine deployment strategy,” he said.
Mnangagwa also said the country could expect a rebound in economic growth this year on the back of stronger agricultural output, which will help improve food “self-sufficiency.” He didn't provide further details.
Zimbabwe's food output has plunged in recent years, with the country reliant on grain imports, including its staple corn, from neighboring South Africa and elsewhere. Aid groups estimate more than half of its almost 15 million people face hunger.
©2021 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.